@article{cc8efdba517846629999c6d48e8b9f19,
title = "Liver Fat, Adipose Tissue, and Body Composition Changes After Switching from a Protease Inhibitor or Efavirenz to Raltegravir",
keywords = "raltegravir, nonalcoholic fatty liver disease, adipocyte, weight gain, adipose tissue, CONTROLLED ATTENUATION PARAMETER, INFECTED PATIENTS, HEPATIC STEATOSIS, ADIPOCYTE SIZE, RISK-FACTORS, HIV, DISEASE, PREVALENCE, INTEGRASE, WOMEN, 3121 General medicine, internal medicine and other clinical medicine, 3142 Public health care science, environmental and occupational health",
author = "Anna Hanttu and Sauli Vuoti and Pia Kivel{\"a} and Perttu Arkkila and Nina Lundbom and Antti Hakkarainen and Jesper Lundbom and Tiina Lehtim{\"a}ki and Hanna Viskari and Ville Lehtinen and Pietil{\"a}inen, {Kirsi H.} and Jussi Sutinen",
year = "2021",
month = sep,
day = "1",
doi = "10.1089/apc.2021.0106",
language = "English",
volume = "35",
pages = "335--341",
journal = "AIDS Patient Care and STDs",
issn = "1087-2914",
publisher = "Mary Ann Liebert",
number = "9",
}